- An asymptomatic patient with a platelet count of 1,100,000/μL has a routine blood test showing a serum potassium of 6.3 mEq/L. A repeat sample drawn and analyzed as whole blood in a point-of-care blood gas analyzer shows a plasma potassium of 4.3 mEq/L. What is the most likely cause of the initial finding?
Answer: Release of intracellular potassium from the large number of platelets during in vitro coagulation.
When you encounter discrepant potassium values in a patient with thrombocytosis, think about the difference between serum and plasma measurements and how cellular components can interfere with laboratory results.
The key insight here is understanding what happens during blood processing. In the initial test, blood was collected in a tube without anticoagulant, allowing it to clot naturally to produce serum. During this clotting process, the massive number of platelets (1,100,000/μL - normal is 150,000-400,000/μL) become activated and release their intracellular contents, including potassium. Since platelets contain high concentrations of intracellular potassium, their lysis during clotting artificially elevates the measured serum potassium to 6.3 mEq/L. This phenomenon is called pseudohyperkalemia.
The repeat sample used anticoagulated whole blood analyzed immediately, preventing platelet activation and degranulation. The plasma potassium of 4.3 mEq/L reflects the patient's true physiologic state.
Option A correctly identifies this mechanism of in vitro potassium release during coagulation. Option B incorrectly suggests systemic release from bone marrow megakaryocytes, but this wouldn't explain the discrepancy between sampling methods. Option C reverses the accuracy - the blood gas analyzer gives the true value, not the serum measurement. Option D proposes true hyperkalemia from renal causes, which doesn't explain why the plasma value is normal.
Remember: When you see discrepant electrolyte values with extreme cell counts, always consider pseudoelectrolyte abnormalities caused by cellular lysis during specimen processing. The anticoagulated sample typically reflects the true physiologic state.
- What is the primary pathophysiological mechanism responsible for this rapid and profound decrease in serum potassium?
Answer: Insulin directly stimulates the activity of the Na+/K+-ATPase pump on cell membranes, driving potassium from the extracellular to the intracellular space.
While correction of acidosis and improved renal function contribute to lowering potassium, the most significant and rapid effect comes from insulin. Insulin directly upregulates the Na+/K+-ATPase pump, which actively transports potassium into cells, causing a rapid shift from the extracellular fluid and a subsequent drop in serum levels.
- A patient with Addison's disease (primary adrenal insufficiency) presents with a serum sodium of 130 mEq/L and a potassium of 6.0 mEq/L. The hyperkalemia is most directly caused by a deficiency in which hormone's action on the principal cells of the collecting duct?
Answer: Aldosterone
In Addison's disease, the adrenal cortex fails to produce adequate mineralocorticoids (aldosterone) and glucocorticoids (cortisol). Aldosterone is the primary hormone responsible for promoting potassium secretion in the principal cells of the collecting duct by upregulating ENaC and ROMK channels. Its deficiency leads to impaired potassium excretion and subsequent hyperkalemia.
- A patient with persistent vomiting develops a serum potassium of 3.0 mEq/L and a serum bicarbonate of 34 mEq/L (metabolic alkalosis). Which mechanism is a major contributor to the hypokalemia in this clinical state?
Answer: Intracellular shifting of K+ in exchange for H+ moving out of cells to buffer the extracellular alkalosis.
In metabolic alkalosis, the extracellular fluid has a deficit of H+ ions. To buffer this change, H+ ions move out of the intracellular fluid into the extracellular fluid. To maintain electroneutrality, this is coupled with the movement of K+ ions from the extracellular fluid into cells via the H+/K+ exchanger. This intracellular shift is a major contributor to the development of hypokalemia in alkalotic states.
- A patient experiences an episode of acute flaccid paralysis after a large carbohydrate meal. Labs during the episode reveal a serum potassium of 2.1 mEq/L. This presentation is classic for hypokalemic periodic paralysis. The paralysis is precipitated by a massive intracellular shift of potassium driven by what physiological trigger?
Answer: An exaggerated muscular response to the post-prandial release of insulin.
In hypokalemic periodic paralysis, individuals (often with an underlying genetic channelopathy) are exquisitely sensitive to the normal physiological effects of insulin. A large carbohydrate meal leads to a significant insulin surge. Insulin potently stimulates the Na+/K+-ATPase pump in skeletal muscle, causing a massive and rapid shift of potassium from the extracellular fluid into the muscle cells. This acute, severe hypokalemia hyperpolarizes the muscle membrane, causing flaccid paralysis.
- A patient with decompensated heart failure is treated with high-dose furosemide. The resulting hypokalemia is primarily a consequence of which downstream renal tubular event?
Answer: Increased delivery of sodium to the distal nephron, which enhances potassium secretion in the principal cells of the collecting duct.
Furosemide blocks the Na-K-2Cl cotransporter in the thick ascending limb. This prevents reabsorption of a large amount of sodium, causing it to be delivered to the distal nephron (collecting duct). The increased sodium load in the collecting duct lumen is reabsorbed via the epithelial sodium channel (ENaC), creating a negative electrical potential in the lumen that drives the secretion of potassium through the ROMK channels. This downstream effect is the main driver of potassium loss.
- A patient with a serum potassium of 7.5 mEq/L and a sinusoidal ECG pattern is given intravenous calcium gluconate. What is the immediate therapeutic mechanism of this intervention?
Answer: It antagonizes the effect of hyperkalemia on cardiac membrane excitability by altering the threshold potential.
Calcium does not lower the serum potassium level. Its immediate, life-saving effect is to stabilize the cardiac membrane. Hyperkalemia depolarizes the resting membrane potential, bringing it closer to the threshold potential and making the heart prone to arrhythmias. Intravenous calcium increases the threshold potential, restoring the normal difference between the resting and threshold potentials and thereby antagonizing the cardiotoxic effects of hyperkalemia without changing the potassium concentration.
- A patient is admitted with crush injuries and rhabdomyolysis. The initial, life-threatening hyperkalemia in this condition results primarily from which process?
Answer: Massive release of intracellular potassium from necrotic skeletal muscle cells into the circulation.
Skeletal muscle contains the vast majority of the body's total potassium stores. In rhabdomyolysis, the sarcolemma of muscle cells is damaged, leading to the massive and rapid release of their intracellular contents, including potassium, into the extracellular fluid and circulation. While concurrent acidosis and acute kidney injury can exacerbate the hyperkalemia, the primary source of the potassium is the damaged muscle tissue itself.
- A patient taking digoxin for atrial fibrillation develops hypokalemia after several days of diarrhea. This combination significantly increases the risk of digoxin toxicity due to which cellular mechanism?
Answer: Potassium and digoxin compete for the same binding site on the Na+/K+-ATPase pump; less potassium results in greater digoxin binding and inhibition.
The Na+/K+-ATPase pump is the therapeutic target of digoxin. Potassium (K+) and digoxin competitively bind to an extracellular site on this pump. When extracellular K+ is low (hypokalemia), there is less competition for this binding site, allowing more digoxin molecules to bind to and inhibit the pump. This enhanced inhibition leads to increased intracellular calcium and a higher risk of arrhythmias and other signs of toxicity.
- An elderly patient with hypertension, type 2 diabetes, and moderate chronic kidney disease is started on lisinopril. This medication increases the risk of hyperkalemia by initiating which of the following physiological cascades?
Answer: Inhibiting angiotensin-converting enzyme, which reduces angiotensin II levels and subsequently decreases aldosterone secretion.
Lisinopril is an ACE inhibitor. It blocks the conversion of angiotensin I to angiotensin II. Angiotensin II is a potent stimulator of aldosterone release from the adrenal glands. By reducing angiotensin II levels, lisinopril causes a decrease in aldosterone secretion. Since aldosterone is crucial for promoting potassium excretion in the distal nephron, its reduction leads to potassium retention and an increased risk of hyperkalemia, especially in patients with pre-existing kidney disease.
- The characteristic peaked T waves seen on an ECG in early hyperkalemia are a direct manifestation of which change in the cardiac action potential?
Answer: An acceleration of the final repolarization phase (Phase 3).
Hyperkalemia increases potassium permeability during repolarization. This increased outward potassium current shortens the duration of the action potential, particularly accelerating Phase 3 (the rapid repolarization phase). On the surface ECG, this is reflected as narrow, tall, or 'peaked' T waves.
- Which statement accurately describes the effect of severe hypokalemia on the resting membrane potential (RMP) of skeletal muscle and its functional consequence?
Answer: It causes hyperpolarization of the RMP, increasing the stimulus required to reach threshold and causing weakness.
The resting membrane potential is largely determined by the ratio of intracellular to extracellular potassium concentration. A decrease in extracellular potassium (hypokalemia) increases this ratio, making the equilibrium potential for potassium more negative. This hyperpolarizes the cell membrane, moving it further away from the threshold potential needed to initiate an action potential, resulting in muscle weakness and paralysis.
- The prominent U waves that appear on an ECG during moderate to severe hypokalemia are thought to represent which underlying electrophysiological event?
Answer: Delayed repolarization of a specific portion of the ventricular conduction system, such as Purkinje fibers.
While the exact origin of the U wave is still debated, the leading hypothesis is that it represents the repolarization of the terminal parts of the intraventricular conduction system, such as the Purkinje fibers or mid-myocardial 'M-cells'. Hypokalemia prolongs the action potential duration in these cells more than in the epicardial or endocardial cells, leading to delayed repolarization that manifests as a distinct wave (the U wave) following the T wave.
- Immediately following successful surgical revascularization of an acutely ischemic limb, a patient develops a life-threatening cardiac arrhythmia. This is most likely precipitated by a sudden systemic surge of potassium originating from what source?
Answer: Washout of potassium from the interstitial fluid and damaged cells of the reperfused ischemic limb.
When you encounter questions about reperfusion injury, focus on what happens when blood flow suddenly returns to previously ischemic tissue. The key pathophysiological concept is that ischemic cells accumulate toxic metabolites and lose membrane integrity, creating a "toxic soup" that gets flushed into systemic circulation upon reperfusion.
During acute limb ischemia, cells experience hypoxia and switch to anaerobic metabolism. This damages cell membranes and disrupts the sodium-potassium pump, causing potassium to leak from intracellular to extracellular spaces. Additionally, cell death releases large amounts of intracellular potassium. When surgical revascularization suddenly restores blood flow, this accumulated potassium gets rapidly washed into the systemic circulation, potentially causing life-threatening hyperkalemia and cardiac arrhythmias.
Option A correctly identifies this washout mechanism from damaged ischemic tissue. Option B is wrong because aldosterone actually promotes potassium excretion, not retention, and wouldn't cause the immediate surge described. Option C misunderstands the metabolic picture—reperfusion typically causes metabolic acidosis (from lactate washout), not alkalosis, and this wouldn't be the primary source of the potassium surge. Option D incorrectly suggests platelets as the source; while platelets do contain some potassium, they're not the major reservoir involved in reperfusion injury.
Study tip: Remember that reperfusion injury involves the "3 K's"—potassium (hyperkalemia), kidney damage (from myoglobin), and cardiac complications. The timing is crucial: these effects happen immediately upon restoration of blood flow, not hours later.
- According to the principle of transcellular shifting, the development of acute metabolic acidosis is expected to affect serum potassium in which of the following ways?
Answer: Increase serum K+ by approximately 0.6 mEq/L per 0.1 unit pH decrease, due to K+ moving out of cells.
When you encounter questions about acid-base disorders and electrolyte shifts, focus on the fundamental principle of transcellular ion exchange. In metabolic acidosis, excess hydrogen ions (H⁺) need to be buffered, and cells play a crucial role in this process.
During acute metabolic acidosis, H⁺ ions move into cells to be buffered by intracellular proteins and phosphates. To maintain electroneutrality, positively charged ions must exit the cell—primarily potassium (K⁺). This creates the classic transcellular shift where acidosis drives potassium out of cells and into the serum.
The established clinical rule is that for every 0.1 unit decrease in pH, serum potassium increases by approximately 0.6 mEq/L. This makes choice A correct—it accurately describes both the magnitude and direction of the shift, along with the correct mechanism.
Choice B has the right magnitude (0.6 mEq/L) but wrong direction—acidosis increases, not decreases, serum K⁺. Choice C suggests the wrong mechanism; while Na⁺/K⁺-ATPase can be affected by severe acidosis, the primary mechanism is H⁺/K⁺ exchange, and 1.5 mEq/L per 0.1 pH unit is too large. Choice D incorrectly focuses on renal excretion, which is a longer-term compensatory mechanism, not the immediate transcellular shifting that occurs in acute acidosis.
Remember: acidosis = H⁺ in, K⁺ out. The 0.6 mEq/L per 0.1 pH unit rule helps you predict the magnitude of hyperkalemia in acidotic patients.
- The widening of the QRS complex in this patient is primarily due to the effect of severe hyperkalemia on which aspect of cardiac electrophysiology?
Answer: Slowing intraventricular conduction velocity due to persistent inactivation of fast sodium channels.
The QRS complex represents ventricular depolarization. Severe hyperkalemia causes a significant partial depolarization of the cardiac myocyte resting membrane potential. This sustained depolarization leads to the prolonged inactivation of a large fraction of fast voltage-gated sodium channels, which are responsible for the rapid upstroke (Phase 0) of the action potential. With fewer available sodium channels, the speed of depolarization and conduction through the ventricular myocardium is slowed, resulting in a widened QRS complex.
- A patient with severe hyperkalemia (serum K+ 7.8 mEq/L) initially experiences muscle twitching, which progresses to flaccid paralysis. Which statement best explains this biphasic neuromuscular response?
Answer: The initial rise in extracellular K+ brings the resting membrane potential closer to threshold, increasing excitability, but sustained depolarization inactivates voltage-gated Na+ channels, preventing subsequent action potentials.
Hyperkalemia reduces the K+ gradient across the cell membrane, causing a partial depolarization of the resting membrane potential (RMP). Initially, this brings the RMP closer to the threshold for firing an action potential, leading to increased excitability (twitching). However, if the depolarization is sustained, voltage-gated sodium channels enter a prolonged inactivated state and cannot recover, rendering the membrane refractory to further stimulation and causing flaccid paralysis.
- Which underlying condition provides the most complete pathophysiological explanation for this constellation of findings?
Answer: Primary hyperaldosteronism, causing hypertension, renal potassium wasting, and metabolic alkalosis.
When you encounter a patient with hypokalemia, metabolic alkalosis, and hypertension, you need to systematically consider the underlying mechanisms that could produce this triad of findings.
Primary hyperaldosteronism perfectly explains this constellation. Excess mineralocorticoid activity causes three key effects: (1) sodium retention leading to hypertension, (2) excessive renal potassium wasting (explaining the high urine K+ of 60 mmol/day), and (3) hydrogen ion loss creating metabolic alkalosis. The profound hypokalemia (2.2 mEq/L) and elevated bicarbonate (36 mEq/L) fit this pathophysiology precisely.
Option B (laxative abuse) would cause hypokalemia and metabolic alkalosis, but you'd expect hypotension from volume depletion, not hypertension. The high urine potassium also doesn't fit, as the kidneys would conserve potassium in response to GI losses.
Option C (surreptitious vomiting) explains the metabolic alkalosis and can cause secondary renal potassium wasting, but again, volume contraction typically produces hypotension, not the hypertension seen here.
Option D (Gitelman syndrome) causes hypokalemia and metabolic alkalosis, but this genetic tubulopathy typically presents with normal or low blood pressure due to salt wasting, not hypertension.
The key distinguishing feature is hypertension combined with renal potassium wasting. This combination specifically points to mineralocorticoid excess, as other causes of hypokalemia with metabolic alkalosis typically cause hypotension or normal blood pressure.
Study tip: Remember the "hyperaldosteronism triad" – hypertension, hypokalemia, and metabolic alkalosis. When you see all three together with high urine potassium, think primary hyperaldosteronism first.
- A genetic disorder characterized by hypokalemia, metabolic alkalosis, and hyperreninemic hyperaldosteronism, which pathophysiologically mimics the chronic use of a loop diuretic due to a defect in the Na-K-2Cl cotransporter, is known as:
Answer: Bartter syndrome
Bartter syndrome is a group of inherited disorders caused by mutations in genes encoding proteins of the Na-K-2Cl cotransporter (NKCC2) or other related channels in the thick ascending limb of the loop of Henle. This defect impairs salt reabsorption, leading to volume depletion, activation of the RAAS (hyperreninemic hyperaldosteronism), and downstream effects of potassium and hydrogen wasting, thus mimicking the exact effects of a loop diuretic like furosemide.
- A patient with primary hyperaldosteronism (Conn's syndrome) presents with hypertension and hypokalemia. The renal potassium wasting in this condition is a direct result of aldosterone-mediated:
Answer: Increased expression and activity of ENaC and ROMK channels on the apical membrane of principal cells.
Aldosterone binds to mineralocorticoid receptors in the principal cells of the distal nephron. This stimulates the synthesis and insertion of more epithelial sodium channels (ENaC) and renal outer medullary potassium (ROMK) channels into the apical (luminal) membrane. Increased ENaC activity enhances sodium reabsorption, making the tubular lumen more electrically negative. This increased negative potential provides a strong driving force for the secretion of positive potassium ions into the lumen through the newly available ROMK channels, leading to potassium wasting and hypokalemia.
